화이자 주식회사
US ˙ NYSE ˙ US7170811035

SecurityPFE / Pfizer Inc.
InstitutionKeel Point, LLC
Latest Disclosed Ownership16,556 shares
Latest Disclosed Value $ 464,901
Keel Point, LLC reports 18.40% decrease in ownership of PFE / Pfizer Inc.

On May 29, 2026 - Keel Point, LLC filed a 13F-HR form disclosing ownership of 16,556 shares of Pfizer Inc. (US:PFE) valued at $464,892 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 20,289 shares of Pfizer Inc.. This represents a change in shares of -18.40% during the quarter. The current value of the position is $431,118 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F PFIZER COM 717081103 16,556 -3,733 -18.40 465 -8.12 0.0301
2026-02-12 2025-12-31 13F PFIZER COM 717081103 20,289 2,034 11.14 505 8.60 0.0304
2025-12-16 2025-09-30 13F PFIZER COM 717081103 18,255 3,093 20.40 465 26.70 0.0286
2025-08-15 2025-06-30 13F PFIZER COM 717081103 15,162 4,238 38.80 368 32.97 0.0243
2025-05-15 2025-03-31 13F PFIZER COM 717081103 10,924 2,911 36.33 277 30.19 0.0215
2025-02-14 2024-12-31 13F PFIZER COM 717081103 8,013 -6,659 -45.39 213 -50.00 0.0170
2024-11-14 2024-09-30 13F PFIZER COM 717081103 14,672 503 3.55 425 3.92 0.0354
2024-08-14 2024-06-30 13F PFIZER COM 717081103 14,169 14,169 409 0.0369
2024-04-16 2024-03-31 13F PFIZER COM 717081103 0 -7,152 -100.00 0 -100.00
2024-01-30 2023-12-31 13F PFIZER COM 717081103 7,152 7,152 206 0.0246
2023-10-26 2023-09-30 13F PFIZER COM 717081103 0 -9,066 -100.00 0 -100.00
2023-07-12 2023-06-30 13F PFIZER COM 717081103 9,066 1,453 19.09 333 7.10 0.0444
2023-04-03 2023-03-31 13F PFIZER COM 717081103 7,613 -2,165 -22.14 311 -38.12 0.0449
2023-01-17 2022-12-31 13F PFIZER COM 717081103 9,778 -1,108 -10.18 501 5.25 0.0786
2022-10-05 2022-09-30 13F PFIZER COM 717081103 10,886 182 1.70 476 -11.03 0.0817
2022-08-11 2022-06-30 13F PFIZER COM 717081103 10,704 936 9.58 535 5.73 0.0834
2022-04-27 2022-03-31 13F PFIZER COM 717081103 9,768 2,275 30.36 506 14.48 0.0759
2022-01-31 2021-12-31 13F PFIZER COM 717081103 7,493 532 7.64 442 47.83 0.0496
2021-11-04 2021-09-30 13F PFIZER COM 717081103 6,961 5,306 320.60 299 -83.60 0.0387
2021-08-06 2021-06-30 13F PFIZER INC COM COM 717081103 1,655 -4,345 -72.42 1,823 740.09 0.4295
2021-05-17 2021-03-31 13F PFIZER COM 717081103 6,000 6,000 217 0.0212
2020-08-14 2020-06-30 13F PFIZER COM 717081103 0 -7,724 -100.00 0 -100.00
2020-05-01 2020-03-31 13F PFIZER COM 717081103 7,724 98 1.29 252 -15.72 0.0326
2020-02-07 2019-12-31 13F PFIZER COM 717081103 7,626 803 11.77 299 22.04 0.0325
2019-11-12 2019-09-30 13F PFIZER COM 717081103 6,823 5 0.07 245 -16.95 0.0299
2019-08-08 2019-06-30 13F PFIZER COM 717081103 6,818 -99 -1.43 295 0.34 0.0337
2019-05-14 2019-03-31 13F PFIZER COM 717081103 6,917 -2,706 -28.12 294 -30.00 0.0340
2019-02-08 2018-12-31 13F Pfizer COM 717081103 9,623 -1,321 -12.07 420 -12.86 0.0569
2018-11-07 2018-09-30 13F Pfizer COM 717081103 10,944 -546 -4.75 482 15.59 0.0599
2018-08-13 2018-06-30 13F Pfizer COM 717081103 11,490 104 0.91 417 3.22 0.0555
2018-05-07 2018-03-31 13F Pfizer COM 717081103 11,386 -202 -1.74 404 -3.81 0.0553
2018-02-08 2017-12-31 13F Pfizer COM 717081103 11,588 -5,241 -31.14 420 -30.12 0.0581
2017-11-09 2017-09-30 13F Pfizer COM 717081103 16,829 -1,956 -10.41 601 -4.75 0.0915
2017-08-15 2017-06-30 13F Pfizer COM 717081103 18,785 -48 -0.25 631 -2.02 0.1267
2017-05-15 2017-03-31 13F Pfizer COM 717081103 18,833 -232 -1.22 644 4.04 0.1301
2017-02-15 2016-12-31 13F Pfizer COM 717081103 19,065 -4,647 -19.60 619 -22.91 0.1390
2016-11-15 2016-09-30 13F Pfizer COM 717081103 23,712 10,078 73.92 803 67.29 0.3050
2016-07-12 2016-06-30 13F Pfizer COM 717081103 13,634 3 0.02 480 18.81 0.2067
2016-05-13 2016-03-31 13F/A-1 Pfizer COM 717081103 13,631 -1,528 -10.08 404 -17.38 0.2036
2016-05-13 2016-03-31 13F Pfizer COM 717081103 13,631 404
2016-02-04 2015-12-31 13F Pfizer COM 717081103 15,159 -215 -1.40 489 1.24 0.2643
2015-11-04 2015-09-30 13F Pfizer COM 717081103 15,374 -10,029 -39.48 483 -44.35 0.2700
2015-07-31 2015-06-30 13F Pfizer COM 717081103 25,403 1,235 5.11 868 3.21 0.4137
2015-05-14 2015-03-31 13F Pfizer COM 717081103 24,168 24,168 841 0.4217
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.